Literature DB >> 21427104

Primary seminal vesicle carcinoma.

Peter Stenzel1, George Wettach, Xavier Leroy.   

Abstract

Criteria for the very rare diagnosis of primary seminal vesicle carcinoma have traditionally been highly stringent but may be relaxed with the application of immunohistochemistry to the diagnosis of mass lesions that occur in the male pelvis. The authors report a case of disseminated carcinoma with a clinically occult primary site that apparently had its origin in the seminal vesicle. Autopsy revealed a 10-cm tumor enveloping the prostate and seminal vesicles without involvement of colonic or urothelial mucosa. Much smaller tumors were present in other sites outside the pelvis. The tumor was composed of poorly formed glands and sheets of malignant-appearing cells, involved the seminal vesicle, and had the immunohistochemical profile of seminal vesicle carcinoma, notably strong immunoreactivity for CA-125 and no immunoreactivity for cytokeratin-20 or prostate-specific markers.

Entities:  

Mesh:

Year:  2011        PMID: 21427104     DOI: 10.1177/1066896911398359

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  3 in total

Review 1.  Maintenance of genomic integrity after DNA double strand breaks in the human prostate and seminal vesicle epithelium: the best and the worst.

Authors:  Sari Jäämaa; Marikki Laiho
Journal:  Mol Oncol       Date:  2012-06-18       Impact factor: 6.603

2.  Metastatic primary seminal vesicle adenocarcinoma: management of a rare tumour with multiagent chemotherapy and hormonal therapy.

Authors:  Hira Lal; Priyank Yadav; Rahul Jena; Manoj Jain
Journal:  BMJ Case Rep       Date:  2017-10-10

3.  Importance of an Early Diagnosis in Primary Adenocarcinoma of the Seminal Vesicle.

Authors:  Lucio Dell'Atti
Journal:  Rare Tumors       Date:  2016-04-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.